HealthcareServices

Biosimilar Testing Services Market Growth Projection: Expected to Surpass $3.37 Billion by 2030 at 12.8% CAGR

February 20, 2026February 20, 2026 by Marketing Posting

Uncover key drivers, emerging technologies, and competitive movements shaping the biosimilar testing services market from 2026–2035 with trusted insights from The Business Research Company

What total market size is anticipated for the Biosimilar Testing Services Market in 2030?

The biosimilar testing services market has experienced substantial expansion in recent years. This market is anticipated to increase from $1.84 billion in 2025 to $2.08 billion in 2026, reflecting a compound annual growth rate (CAGR) of 13.0%. Historically, this growth can be attributed to several factors including the expansion of biosimilar development pipelines, a rise in regulatory approvals for biosimilars, the growth of biologics manufacturing, an increasing reliance on CRO testing services, and enhancements in analytical testing technologies.

The biosimilar testing services market is projected to experience substantial expansion over the upcoming years. This market is forecast to reach $3.37 billion by 2030, exhibiting a compound annual growth rate (CAGR) of 12.8%. The anticipated growth during this period stems from several factors, including the increasing need for economical biologic options, the broadening of global biosimilar markets, the heightened intricacy of biologic molecules, a greater emphasis on comparability studies, and increased funding in biosimilar research and development. Key trends for the forecast period encompass a heightened requirement for thorough analytical characterization, the increasing use of sophisticated bioanalytical assays, a stronger commitment to regulatory-compliant testing services, the broadening of outsourced support for biosimilar development, and an intensified focus on validating methods and ensuring consistency.

Access Your Free Sample Report for In-Depth Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=27225&type=smp

What Drivers Are Influencing Production Trends In The Biosimilar Testing Services Market?

The increasing incidence of autoimmune conditions is anticipated to propel the growth of the biosimilar testing services market going forward. Autoimmune diseases are conditions where the body’s immune system mistakenly attacks its own healthy cells and tissues, leading to inflammation and tissue damage. The rising prevalence of autoimmune diseases is attributed to the growing necessity for effective biologic treatments that can manage chronic symptoms, reduce flare-ups, and improve long-term patient outcomes. Biosimilar testing services aid in the treatment of autoimmune diseases by ensuring biosimilars are safe, effective, and comparable to original biologics, thereby helping to provide affordable and accessible therapeutic options. For instance, in February 2024, according to the Arthritis Australia, an Australia-based non-profit organization, an estimated 562,378 Australians will be living with RA in 2025, making up 14% of all arthritis cases that year. By 2040, this number is projected to increase by 33% to 748,721 people. This signifies an increase of 186,343 Australians with RA compared with 2025. Therefore, the growing prevalence of autoimmune diseases is driving the growth of the biosimilar testing services market.

Which Segment Groups Are Influencing The Biosimilar Testing Services Market?

The biosimilar testing services market covered in this report is segmented –

1) By Service Type: Analytical Testing, Bioanalytical Testing, Stability Testing, Method Development And Validation, Other Service Types

2) By Technology: Cell-Based Assays, Chromatography Techniques, Mass Spectrometry, Bioassays

3) By Molecule Type: Monoclonal Antibodies, Recombinant Hormones, Insulin, Interferons, Enzymes, Other Molecule Types

4) By Application: Oncology, Autoimmune Diseases, Blood Disorders, Growth Hormone Deficiency, Other Applications

5) By End User: Pharmaceutical Companies, Biotechnology Companies, Contract Research Organizations, Academic Research Institutes, Government Agencies

Subsegments:

1) By Analytical Testing: Protein Characterization, Impurity Profiling, Potency Testing, Glycosylation Analysis, Structural Analysis

2) By Bioanalytical Testing: Pharmacokinetics Analysis, Immunogenicity Testing, Biomarker Analysis, Drug Concentration Measurement, Toxicokinetics Testing

3) By Stability Testing: Long-Term Stability Testing, Accelerated Stability Testing, Stress Testing, Photostability Testing, Temperature Cycling Studies

4) By Method Development And Validation: Analytical Method Development, Bioanalytical Method Development, Method Validation, Process Validation, Assay Development

5) By Other Service Types: Immunogenicity Assessment, Formulation Development, Microbial Testing, Release Testing, Regulatory Consulting

What Industry Trends Are Transforming The Biosimilar Testing Services Market?

Leading firms within the biosimilar testing services market are prioritizing facility expansion to integrate novel technologies and capabilities, thereby boosting efficiency and competitive edge. Such expansion involves either increasing the size or improving the current physical premises or infrastructure to meet growing operational demands or anticipated future development. An example occurred in October 2023 when Tanvex BioPharma USA Inc., a US biotechnology firm, unveiled Tanvex CDMO in San Diego. This advanced contract development and manufacturing organization delivers comprehensive biologics development and manufacturing solutions, encompassing cell line development, process refinement, analytical assessments, and regulatory assistance. The goal of this new establishment is to expedite the progression of biopharmaceutical products from initial concept to commercial production, utilizing sophisticated technologies and skilled personnel to provide groundbreaking and transformative biologics to global patients.

Who Are The Major Companies Operating In The Biosimilar Testing Services Market?

Major companies operating in the biosimilar testing services market are Thermo Fisher Scientific Inc., IQVIA Laboratories, Laboratory Corporation of America Holdings, Eurofins Scientific SE, SGS Société Générale de Surveillance SA, WuXi AppTec Co. Ltd., Intertek Group plc, Samsung Biologics Co. Ltd., Almac Group Limited, Syngene International Limited, Shanghai Medicilon Inc., Kymos Group S.L., Pacific BioLabs Inc., Profacgen Inc., ExcellGene SA, BioPharmaSpec Ltd., Charles River Laboratories International Inc., Covance Inc., PPD Inc., ICON plc, Parexel International Corporation, Frontage Laboratories Inc.

Access The Complete Report For Deeper Market Insights:

https://www.thebusinessresearchcompany.com/report/biosimilar-testing-services-global-market-report

Which Region Is Anticipated To See The Fastest Growth In The Biosimilar Testing Services Market?

North America was the largest region in the biosimilar testing services market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the biosimilar testing services market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request Your Customized Biosimilar Testing Services Market Research Report for Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=27225&type=smp

Browse Through More Reports Similar to the Global Biosimilar Testing Services Market 2026, By The Business Research Company

Technical Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/technical-insulation-global-market-report

Insulation Products Market Report 2026

https://www.thebusinessresearchcompany.com/report/insulation-products-global-market-report

Aircraft Insulation Market Report 2026

https://www.thebusinessresearchcompany.com/report/aircraft-insulation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795